FNY Investment Advisers, LLC

Position in ABBV — AbbVie Inc.

CIK 1742998 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$2,516

New position

Shares Held

10

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#4,146

of 4,153 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $3,050,095 across 6 Drug Manufacturers - General names. ABBV ranks #6 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,393	$1,670,806
2	PFE	Pfizer Inc	50,150	$1,207,612
3	MRK	Merck & Co., Inc.	596	$76,586
4	NVO	Novo Nordisk A S	1,140	$54,651
5	AZN	Astrazeneca PLC	200	$37,924
6	ABBV	AbbVie Inc. This page	10	$2,516

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,516	10	—	Shares	Defined	2026-07-08
No filing history on record for this holder in this stock.